Close Menu

NEW YORK (GenomeWeb) – Clinical genomic testing company Variantyx has received a $7 million investment from Israeli firm Pitango Venture Capital.

Pitango, based in Herzliya, said today that the funding round is part of its new Pitango HealthTech Fund, which the firm aims to close at $150 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.